Increased erythrocyte uroporphyrinogen-I-synthetase, δ-aminolevulinic acid dehydratase and protoporphyrin in hemolytic anemias

      This paper is only available as a PDF. To read, Please Download here.


      Heme pathway enzymes and protoporphyrin in red cells are sensitive indices of derangements in heme biosynthesis, and assays for them are useful in the diagnosis of porphyrias, lead poisoning and iron deficiency in man. In this study the consequences of hemolysis and increased proportions of circulating young erythrocytes on activities of uroporphyrinogen-I-synthetase (UROS), δ-aminolevulinic acid dehydratase (ALAD) and protoporphyrin content were examined. UROS was strikingly increased in 25 patients with severe chronic hemolysis due to hemoglobinopathies (hemoglobins SS, SC or S-β-thalassemia). This enzyme was also increased in a group of 12 patients with other hemolytic disorders, but it was normal in most subjects with β-thalassemia trait and less evidence of hemolysis. Erythrocyte ALAD and protoporphyrin also were commonly increased, and mean values were significantly higher in patients with severe hemoglobinopathies, β-thalassemia trait and other forms of hemolysis. Reticulocyte counts correlated better with UROS activity than with protoporphyrin or ALAD in red cells. UROS, and to a lesser degree ALAD and protoporphyrin, were greater in younger than in older red cells after partial separation by specific gravity, using blood from normal subjects, and from those with acute intermittent porphyria and sickle cell anemia. Heme pathway components in human red cells, therefore, are sensitive to changes in red cell turnover and red cell age, in addition to a variety of other known genetic, developmental and environmental factors. They may serve as useful indicators of the proportion of young erythrocytes in the peripheral circulation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Meyer UA
        • Strand LJ
        • Doss M
        • et al.
        Intermittent acute porphyria. Demonstration of a genetic defect in porphobilinogen metabolism.
        N Engl J Med. 1972; 286: 1277
        • Sassa S
        • Granick S
        • Bickers DR
        • et al.
        A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.
        in: 4th ed. Proc Natl Acad Sci USA. 71. 1974: 732
        • Sassa S
        • Solish G
        • Levere RD
        • et al.
        Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
        J Exp Med. 1975; 142: 722
        • Lamola AA
        • Piomelli S
        • Poh-Fitzpatrick MB
        • et al.
        Erythropoietic protoporphyria and lead intoxication. The molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin.
        J Clin Invest. 1975; 56: 1528
        • Granick JL
        • Sassa S
        • Granick S
        • et al.
        Studies in lead poisoning. II. Correlation between the ratio of activated to inactivated δ-aminolevulinic acid dehydratase of whole blood and the blood lead level.
        Biochem Med. 1973; 8: 149
        • Sassa S
        • Granick JL
        • Granick S
        • et al.
        Studies in lead poisoning. I. Microanalysis of erythrocyte protoporphyrin levels by spectrofluorometry in the detection of chronic lead intoxication in the subclinical range.
        Biochem Med. 1973; 8: 135
        • Harris JW
        • Kellermeyer RW
        The Red Cell.
        in: Harvard University Press, Cambridge1970: 468
        • Beutler E
        4th ed. Red Cell Metabolism, a Manual of Biochemical Methods. Grune & Stratton, New York1975
        • Marks PA
        • Johnson AB
        • Hirschberg E
        • et al.
        Studies on the mechanism of aging of human red blood cells.
        Ann NY Acad Sci. 1958; 75: 95
        • Sassa S
        • Granick S
        • Bickers DR
        • et al.
        Studies on the inheritance of human erythrocyte δ-aminolevulinate dehydratase and uroporphyrinogen synthetase.
        Enzyme. 1973; 16: 326
        • Brecher G
        New methylene blue as a reticulocyte stain.
        Am J Clin Pathol. 1949; 19: 895
        • Murphy JR
        Influence of temperature and method of centrifugation on the separation of erythrocytes.
        J Lab Clin Med. 1973; 82: 334
        • Granick S
        • Sassa S
        δ-Aminolevulinic acid synthetase and the control of heme and chlorophyll synthesis.
        in: 4th ed. Metabolic Regulation. vol 5. Academic Press, New York1971: 77
        • Russell RL
        • Coleman DL
        Genetic control of hepatic δ-aminolevulinate dehydratase in mice.
        Genetics. 1963; 48: 1033
        • Hutton JJ
        • Coleman DL
        Linkage analysis using biochemical variants in mice. II. Levulinate dehydratase and autosomal glucose 6-phosphate dehydrogenase.
        Biochem Genet. 1969; 3: 517
        • Sassa S
        • Bernstein SE
        Levels of δ-aminolevulinate dehydratase, uroporphyrinogen-I-synthase, and protoporphyrin IX in erythrocytes from anemic mutant mice.
        in: 4th ed. Proc Natl Acad Sci USA. 74. 1977: 1181
        • Granick S
        • Sassa S
        • Granick JL
        • et al.
        Assays for porphyrins, δ-aminolevulinic-acid dehydratase, and porphyrinogen synthetase in microliter samples of whole blood: applications to metabolic defects involving the heme pathway.
        in: 4th ed. Proc Natl Acad Sci USA. 69. 1972: 2381
        • Vavra JD
        • Mayer VK
        In vitro porphyrin synthesis by human blood porphyrin synthesis by thalassemic erythrocytes.
        J Lab Clin Med. 1964; 63: 754
        • Feldman F
        • Lichtman HC
        In vitro porphobilinogen and porphyrin synthesis in thalassemia major and sickle cell anemia.
        Ann NY Acad Sci. 1964; 119: 540
        • Heilmeyer L
        Disturbances of Heme Synthesis.
        Charles C Thomas, Springfield1964
        • Piomelli S
        • Corash LM
        • Davenport DD
        • et al.
        In vivo lability of glucose-6-phosphate dehydrogenase in GdA− and GDMediterranean deficiency.
        J Clin Invest. 1968; 47: 940
        • Bloomer JR
        • Berk PD
        • Bonkowsky HL
        • et al.
        Blood volume and bilirubin production in acute intermittent porphyria.
        N Engl J Med. 1971; 284: 17
        • Nordmann Y
        • Grandchamp B
        • Grelier M
        • et al.
        Detection of intermittent acute porphyria trait in children.
        Lancet. 1976; 2: 201